Closing in on advanced prostate cancer

A team headed by Xavier Salvatella, ICREA researcher at the Institute for Research in Biomedicine (Barcelona), has discovered a new avenue through which to attack prostrate cancer cells that have developed drug-resistance. Published in the journal Structure, part of the Cell group, the study opens up new therapeutic avenues against a disease that causes 75,000 deaths a year in Europe alone.
Science Daily